tetano
Editor, Senior Moderator
Front Immunol
. 2023 Nov 15:14:1264160.
doi: 10.3389/fimmu.2023.1264160. eCollection 2023. A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
Zhengchao Lv[SUP] #[/SUP][SUP] 1 2 [/SUP], Songqin Lv[SUP] #[/SUP][SUP] 3 [/SUP], Qin Li[SUP] 1 [/SUP], Yafei Xia[SUP] 4 [/SUP], Zaineng Feng[SUP] 5 [/SUP], Haohong Zhang[SUP] 1 [/SUP], Haihao Yang[SUP] 1 [/SUP], Zhao Wu[SUP] 1 [/SUP], Nanting Zou[SUP] 1 [/SUP], Qingyan Mo[SUP] 1 [/SUP], Qianlan Gu[SUP] 6 [/SUP], Sai Ying[SUP] 1 [/SUP], Xicheng Wang[SUP] 2 [/SUP], Dongdong Qin[SUP] 7 [/SUP], Chunping Wan[SUP] 1 [/SUP]
Affiliations
Introduction: This study sought to explore the immunogenicity of a booster dose of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in people living with human immunodeficiency virus (HIV) and identify the factors affecting the magnitude of anti-SARS-CoV-2 antibody levels.
Materials and methods: A total of 34 people living with HIV (PLWH) and 34 healthy donors (HD) were administered a booster dose of the same SARS-CoV-2 vaccine. Anti-SARS-CoV-2 antibody and immunoglobulin G (IgG) levels were measured using the SARS-CoV-2 S protein neutralizing antibody Enzyme-Linked Immunosorbent Assay (ELISA) and 2019-nCov IgG Chemiluminescent Immunoassay Microparticles, respectively. Spearman correlation analysis was used to measure the correlation between laboratory markers and neutralizing antibody and IgG levels. Peripheral blood mononuclear cells (PBMCs) were extracted from each subject using density gradient centrifugation and the numbers of memory T and T follicular helper (Tfh) cells were determined using flow cytometry.
Results: PLWH had a marked reduction in CD4 and B cell levels that was accompanied by a lower CD4/CD8 T cell ratio. However, those who received a supplementary dose of inactivated SARS-CoV-2 vaccines exhibited antibody positivity rates that were analogous to levels previously observed. The booster vaccine led to a reduction in IgG and neutralizing antibody levels and the amplitude of this decline was substantially higher in the PLWH than HD group. Correlation analyses revealed a strong correlation between neutralizing antibody levels and the count and proportion of CD4 cells. Anti-SARS-CoV-2 IgG antibody levels followed a similar trend. The expression of memory T and Tfh cells was considerably lower in the PLWH than in the HD group.
Discussion: PLWH had an attenuated immune response to a third (booster) administration of an inactivated SARS-CoV-2 vaccine, as shown by lower neutralizing antibody and IgG levels. This could be attributed to the reduced responsiveness of CD4 cells, particularly memory T and cTfh subsets. CD4 and cTfh cells may serve as pivotal markers of enduring and protective antibody levels. Vaccination dose recalibration may be critical for HIV-positive individuals, particularly those with a lower proportion of CD4 and Tfh cells.
Keywords: PLWH; T follicular helper cells; booster dose; immunogenicity; inactivated SARS-CoV-2 vaccines.
. 2023 Nov 15:14:1264160.
doi: 10.3389/fimmu.2023.1264160. eCollection 2023. A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
Zhengchao Lv[SUP] #[/SUP][SUP] 1 2 [/SUP], Songqin Lv[SUP] #[/SUP][SUP] 3 [/SUP], Qin Li[SUP] 1 [/SUP], Yafei Xia[SUP] 4 [/SUP], Zaineng Feng[SUP] 5 [/SUP], Haohong Zhang[SUP] 1 [/SUP], Haihao Yang[SUP] 1 [/SUP], Zhao Wu[SUP] 1 [/SUP], Nanting Zou[SUP] 1 [/SUP], Qingyan Mo[SUP] 1 [/SUP], Qianlan Gu[SUP] 6 [/SUP], Sai Ying[SUP] 1 [/SUP], Xicheng Wang[SUP] 2 [/SUP], Dongdong Qin[SUP] 7 [/SUP], Chunping Wan[SUP] 1 [/SUP]
Affiliations
- PMID: 38045691
- PMCID: PMC10690609
- DOI: 10.3389/fimmu.2023.1264160
Introduction: This study sought to explore the immunogenicity of a booster dose of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in people living with human immunodeficiency virus (HIV) and identify the factors affecting the magnitude of anti-SARS-CoV-2 antibody levels.
Materials and methods: A total of 34 people living with HIV (PLWH) and 34 healthy donors (HD) were administered a booster dose of the same SARS-CoV-2 vaccine. Anti-SARS-CoV-2 antibody and immunoglobulin G (IgG) levels were measured using the SARS-CoV-2 S protein neutralizing antibody Enzyme-Linked Immunosorbent Assay (ELISA) and 2019-nCov IgG Chemiluminescent Immunoassay Microparticles, respectively. Spearman correlation analysis was used to measure the correlation between laboratory markers and neutralizing antibody and IgG levels. Peripheral blood mononuclear cells (PBMCs) were extracted from each subject using density gradient centrifugation and the numbers of memory T and T follicular helper (Tfh) cells were determined using flow cytometry.
Results: PLWH had a marked reduction in CD4 and B cell levels that was accompanied by a lower CD4/CD8 T cell ratio. However, those who received a supplementary dose of inactivated SARS-CoV-2 vaccines exhibited antibody positivity rates that were analogous to levels previously observed. The booster vaccine led to a reduction in IgG and neutralizing antibody levels and the amplitude of this decline was substantially higher in the PLWH than HD group. Correlation analyses revealed a strong correlation between neutralizing antibody levels and the count and proportion of CD4 cells. Anti-SARS-CoV-2 IgG antibody levels followed a similar trend. The expression of memory T and Tfh cells was considerably lower in the PLWH than in the HD group.
Discussion: PLWH had an attenuated immune response to a third (booster) administration of an inactivated SARS-CoV-2 vaccine, as shown by lower neutralizing antibody and IgG levels. This could be attributed to the reduced responsiveness of CD4 cells, particularly memory T and cTfh subsets. CD4 and cTfh cells may serve as pivotal markers of enduring and protective antibody levels. Vaccination dose recalibration may be critical for HIV-positive individuals, particularly those with a lower proportion of CD4 and Tfh cells.
Keywords: PLWH; T follicular helper cells; booster dose; immunogenicity; inactivated SARS-CoV-2 vaccines.